Frontiers | CSF p-tau as a potential cognition impairment biomarker in ALS
Norovirus P particle-based tau vaccine-generated phosphorylated tau antibodies markedly ameliorate tau pathology and improve behavioral deficits in mouse model of Alzheimer's disease | Signal Transduction and Targeted Therapy
Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease - ScienceDirect
Frontiers | Hyperphosphorylation of Tau Associates With Changes in Its Function Beyond Microtubule Stability
Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models | eLife
Frontiers | Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau in vivo
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study - The Lancet Neurology
Targeted Dephosphorylation of Tau by Phosphorylation Targeting Chimeras (PhosTACs) as a Therapeutic Modality | Journal of the American Chemical Society
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease | Nature Communications
JCI - CHIP-ping away at tau
Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease - ScienceDirect
Cis P-tau in the CSF of severe TBI patients is neurotoxic and... | Download Scientific Diagram
Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies - ScienceDirect
BBRC researchers identify new tau biomarkers to detect the preclinical phase of Alzheimer's disease | Barcelona Beta
Phospho-tau/tau Ratios: Better Markers than Absolute p-Tau Levels? | ALZFORUM
Frontiers | Tau: A Signaling Hub Protein
Earliest of Them All: Blood P-Tau231 Assay Flags Pre-Amyloid Alzheimer's | ALZFORUM
Phospho-Tau (Ser46) Antibody | Cell Signaling Technology
p-Tau Antibody (PHF-6) | SCBT - Santa Cruz Biotechnology
P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles | Alzheimer's Research & Therapy | Full Text
Phospho-Tau (Ser202, Thr205) Monoclonal Antibody (AT8) (MN1020)
Levels of phospho-tau (P-tau; antibodies AT8 and PHF13) and total tau... | Download Scientific Diagram
Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia | ACS Chemical Neuroscience
Approach - Pinteon Therapeutics
Amyloid-associated increases in soluble tau is a key driver in accumulation of tau aggregates and cognitive decline in early Alzheimer | medRxiv
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia | Nature Medicine
